All News

Despite an increase in HIV and poorer clinical outcomes among migrant populations, the uptake of PrEP among these individuals has been understudied.

Expert Nikhil Palekar, MD, said that although the treatment is far from a cure, it is a vital first step toward other treatments for Alzheimer Disease.

Diagnostic technologies are advancing quickly, which may lead to therapeutics for age-related diseases to safely reduce chronic low-grade inflammation generated by the immune system.

Physically active individuals who had fewer than 6 hours of sleep showed faster cognitive decline overall.

Oncology pharmacy is best learned in real time with real oncologists and real patients.

Clinical pharmacy services became eligible for reimbursement by all health insurance in Germany; however, challenges persist in upscaling and sustaining these services.

The novel treatment may be able to generate new cardiac tissue to create a functional human heart muscle.

Community health worker training can allow the technician to perform to the top of their abilities and improve access to the pharmacy’s public health services.

Studies consistently demonstrate the pivotal involvement of neuropeptide calcitonin gene related peptide release in migraine onset.

Lucas Morgan, Esq, a partner at Frier Levitt, discusses how to navigate the Board of Pharmacy as a pharmacist.

Lecanemab-irmb is the first amyloid beta-directed antibody to be converted from an accelerated approval to a traditional approval for the treatment of Alzheimer disease.

In a study of individuals with Medicare, the incidence of type 2 diabetes was associated with approximately $30,000 to $98,000 excess lifetime medical expenditures.

Pirtobrutinib is a non–covalent (reversible) BTK inhibitor, demonstrating a 73.3% overall response rate with a median follow-up of 19.4 months among patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

mRNA-1345 is a vaccine indicated for the prevention of respiratory syncytial virus-associated lower respiratory tract disease and acute respiratory disease.

Nonpharmacologic and nonopioid treatments associated with improvements in pain and/or function that appear comparable to opioid treatments.

Despite recommendations for adults to receive lung cancer screenings, rates have remained low compared with other cancer screening programs.

COVID-19 is helping to shape current pharmacy practice, including increased vaccinations, access to care, and better interactions with patients.

The safety and efficacy of long-term benzodiazepine use beyond the recommended timeframe is not well understood.

The benefits of the survey can stretch beyond assessing the parental acceptability of mental health screenings in children and can suggest areas of optimization in providing these screenings more widely and effectively in the future.

More than half of the patients prescribed oral anticancer agents report persistent moderate-to-severe symptoms, despite receiving counseling on adverse effect management.

On this episode of Public Health Matters, Christina Madison speaks with Lydia Bailey, PharmD, BCACP, pharmacy operations manager for St. Vincent de Paul Charitable Pharmacy in Cincinnati, Ohio about what charitable pharmacies are.

The blood pressure drug could provide relief for veterans and service members suffering from traumatic brain injuries.

To slow the production of MCI and dementia, utilizing more ways of establishing the diagnoses for women can prevent the progression.

The impact of smoke caused by Canadian wildfires raises concern for wildfire–related fine particles.

An expert panel discussed the outreach of social determinants of health in community pharmacy care and how pharmacists can help patients find and access resources.

If finalized, the regulation would potentially reduce prescription nonadherence and accidental misuse.

Adalimumab-adaz HCF in the 100 mg/mL strength is approved for indications that are no longer covered exclusively for the reference Humira after July 2023.

Pharmacists can use their knowledge and professional judgment to educate patients about when it is appropriate to take these medications and when to avoid them.